The European Commission is asking for comments on a new, wide-ranging strategy aimed at ensuring patients have access to safe, affordable and high-quality drugs across Europe.

House Democrats are calling for more details of the Trump administration’s coronavirus research contracts with pharma companies.

Citing a substantially increased volume of requests for expanded access to investigational drugs to treat COVID-19, the FDA has issued a final guidance that clarifies the conditions under which it will consider sponsor and investigator requests for waivers from full IRB review.